• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对转基因油菜籽73496的2024年上市后监测报告的评估。

Assessment of the 2024 post-market monitoring report of genetically modified oilseed rape 73496.

作者信息

Ardizzone Michele, Frenzel Thomas, Gomez Ruiz José Ángel, Goumperis Tilemachos, Savoini Giovanni, Ornsrud Robin, Sánchez-Brunete Elena, Schoonjans Reinhilde

出版信息

EFSA J. 2025 Jul 10;23(7):e9579. doi: 10.2903/j.efsa.2025.9579. eCollection 2025 Jul.

DOI:10.2903/j.efsa.2025.9579
PMID:40642285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12242049/
Abstract

Following a request from the European Commission (EC), the European Food Safety Authority (EFSA) analysed the 2024 post-market monitoring (PMM) report of genetically modified oilseed rape (OSR) 73496 and the additional information provided during the assessment. EFSA concluded that the assumptions for consumption and for the intended uses considered during the pre-market risk assessment (human and animal dietary exposure) remain valid. The authorisation holder did not provide consumption data for humans and animals of OSR 73496 and of products derived from OSR 73496 as requested in the authorisation. However, EFSA concluded that the methodology used and the information provided is sufficient to conclude that the conditions considered during the pre-market risk assessment are still applicable.

摘要

应欧盟委员会(EC)的要求,欧洲食品安全局(EFSA)分析了转基因油菜籽(OSR)73496的2024年上市后监测(PMM)报告以及评估期间提供的补充信息。EFSA得出结论,上市前风险评估(人类和动物膳食暴露)期间考虑的消费和预期用途假设仍然有效。授权持有人未按授权要求提供OSR 73496以及源自OSR 73496的产品的人类和动物消费数据。然而,EFSA得出结论,所使用的方法和提供的信息足以得出结论,即上市前风险评估期间考虑的条件仍然适用。

相似文献

1
Assessment of the 2024 post-market monitoring report of genetically modified oilseed rape 73496.对转基因油菜籽73496的2024年上市后监测报告的评估。
EFSA J. 2025 Jul 10;23(7):e9579. doi: 10.2903/j.efsa.2025.9579. eCollection 2025 Jul.
2
Statement complementing the EFSA Scientific Opinion on the assessment of genetically modified oilseed rape MS11 for food and feed uses, import and processing, under Regulation (EC) No 1829/2003 (application EFSA-GMO-BE-2016-138).关于根据(欧盟)第1829/2003号法规(申请编号:EFSA-GMO-BE-2016-138)对用于食品、饲料、进口和加工的转基因油菜籽MS11进行评估的欧洲食品安全局科学意见的补充声明。
EFSA J. 2022 Mar 11;20(3):e07190. doi: 10.2903/j.efsa.2022.7190. eCollection 2022 Mar.
3
Assessment of genetically modified oilseed rape T45 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-012).根据欧盟法规(EC)No 1829/2003对转基因油菜籽T45进行重新授权评估(申请编号EFSA-GMO-RX-012)。
EFSA J. 2019 Feb 14;17(2):e05597. doi: 10.2903/j.efsa.2019.5597. eCollection 2019 Feb.
4
Assessment of the feed additive consisting of 6-phytase (produced with CBS 126897) (Quantum® Blue) for the renewal of its authorisation for poultry, weaned piglets, pigs for fattening and sows (4a19), and its extension of use to other porcine species and ornamental birds (AB Enzymes Finland Oy).评估由6-植酸酶(由CBS 126897生产)(Quantum® Blue)组成的饲料添加剂,以更新其在家禽、断奶仔猪、育肥猪和母猪(4a19)方面的授权,并将其使用范围扩大到其他猪种和观赏鸟(芬兰AB酶公司)。
EFSA J. 2025 Jun 18;23(6):e9463. doi: 10.2903/j.efsa.2025.9463. eCollection 2025 Jun.
5
Assessment of genetically modified oilseed rape GT73 for placing on the market of isolated seed protein for food under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-026/2).根据(欧盟)第1829/2003号法规(申请编号EFSA-GMO-RX-026/2)对用于食品的分离种子蛋白投放市场的转基因油菜籽GT73进行评估。
EFSA J. 2022 Nov 4;20(11):e07590. doi: 10.2903/j.efsa.2022.7590. eCollection 2022 Nov.
6
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.
7
Scientific Opinion on application EFSA-GMO-NL-2013-119 for authorisation of genetically modified glufosinate-ammonium- and glyphosate-tolerant oilseed rape MON 88302 × MS8 × RF3 and subcombinations independently of their origin, for food and feed uses, import and processing submitted in accordance with Regulation (EC) No 1829/2003 by Monsanto Company and Bayer CropScience.关于孟山都公司和拜耳作物科学公司依据欧盟法规(EC)No 1829/2003提交的耐草铵膦和草甘膦转基因油菜籽MON 88302×MS8×RF3及其独立于来源的亚组合用于食品、饲料用途、进口和加工的申请(EFSA-GMO-NL-2013-119)的科学意见
EFSA J. 2017 Apr 10;15(4):e04767. doi: 10.2903/j.efsa.2017.4767. eCollection 2017 Apr.
8
Assessment of genetically modified maize NK603 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2023-21250).根据(欧盟)第1829/2003号法规对转基因玉米NK603进行再授权评估(档案GMFF-2023-21250)。
EFSA J. 2025 Jun 20;23(6):e9505. doi: 10.2903/j.efsa.2025.9505. eCollection 2025 Jun.
9
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
10
Assessment of genetically modified oilseed rape MS8, RF3 and MS8×RF3 for renewal of authorisation under regulation (EC) No 1829/2003 (application EFSA-GMO-RX-004).根据(欧盟)第1829/2003号法规(申请EFSA-GMO-RX-004)对转基因油菜籽MS8、RF3和MS8×RF3进行重新授权评估。
EFSA J. 2017 Nov 28;15(11):e05067. doi: 10.2903/j.efsa.2017.5067. eCollection 2017 Nov.

本文引用的文献

1
Assessment of genetically modified oilseed rape 73496 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2012-109).根据(欧盟)第1829/2003号法规(申请编号EFSA-GMO-NL-2012-109)对转基因油菜籽73496进行食品和饲料用途评估。
EFSA J. 2021 Jun 17;19(6):e06610. doi: 10.2903/j.efsa.2021.6610. eCollection 2021 Jun.